SARS-CoV-2 Seroprevalence in Canada

This dataset contains population level infection-acquired and vaccine-induced seroprevalence estimates stratified by geography (Canada or by province), social determinants and age group. Data were compiled from over 20 research studies collaborating with the CITF. Trends in SARS-CoV-2 seroprevalence owing to infection and vaccination were then estimated by geographical region using a time-series approach. The analysis was conducted using a Bayesian framework and generalized linear multilevel models for β-binomial distributed outcomes.